Insights

Global partnerships LivFul emphasizes collaboration with academia, NGOs, micro-businesses, and multinational corporations to disseminate health innovations, suggesting sales opportunities through channel partnerships, licensing agreements, and joint ventures across regions.

Insect-borne disease focus Recent product launches and expansions highlight a strong emphasis on DEET-free, plant-based insect repellents and malaria protection, presenting upsell and cross-sell potential to healthcare providers, NGOs, and government health programs in malaria-endemic markets.

European expansion Facility expansion into Liverpool and Northern Europe signals a regional growth push; sales teams can target European distributors, research partners, and public health agencies to accelerate market entry and co-development deals.

Sustainable tech stack Adopting cloud, web, and analytics technologies indicates readiness for scalable solutions and data-driven partnerships; opportunities exist to offer integrated health innovations, digital health tools, or partner-assisted deployment with performance tracking.

Mid-market footprint With revenue in the mid tens of millions and a lean employee base, LivFul presents as a nimble partner for mid-market distributors and regional players seeking innovative, impact-driven health solutions with clear social value.

Similar companies to LivFul, Inc.

LivFul, Inc. Tech Stack

LivFul, Inc. uses 8 technology products and services including Amazon Web Services, Open Graph, Squarespace, and more. Explore LivFul, Inc.'s tech stack below.

LivFul, Inc.'s Email Address Formats

LivFul, Inc. uses at least 2 email formats:
LivFul, Inc. Email FormatsExamplePercentage
FLast@livful.comJDoe@livful.com
97%
First.Last@livful.comJohn.Doe@livful.com
3%

Frequently Asked Questions

What is LivFul, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
LivFul, Inc.'s official website is livful.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does LivFul, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, LivFul, Inc.'s annual revenue is estimated to be $25M - $50M.

What is LivFul, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
LivFul, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LivFul, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, LivFul, Inc. has approximately 35 employees across 5 continents, including Europe, North America and Asia. Key team members include Chief Scientific Officer: J. R., Chief Commercial Officer: F. Y. and Chief Operations Officer: J. M. Explore LivFul, Inc.'s employee directory with LeadIQ.

What industry does LivFul, Inc. belong to?

Minus sign iconPlus sign icon
LivFul, Inc. operates in the Biotechnology Research industry.

What technology does LivFul, Inc. use?

Minus sign iconPlus sign icon
LivFul, Inc.'s tech stack includes Amazon Web Services, Open Graph, Squarespace, WordPress, Shopify, Squarespace Commerce, Microsoft 365 and Webflow.

What is LivFul, Inc.'s email format?

Minus sign iconPlus sign icon
LivFul, Inc.'s email format typically follows the pattern of FLast@livful.com. Find more LivFul, Inc. email formats with LeadIQ.

How much funding has LivFul, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, LivFul, Inc. has raised $12M in funding. The last funding round occurred on Dec 16, 2025 for $1.5M.

When was LivFul, Inc. founded?

Minus sign iconPlus sign icon
LivFul, Inc. was founded in 2015.
LivFul, Inc. logo

LivFul, Inc.

Biotechnology ResearchGeorgia, United States11-50 Employees

LivFul, Inc. is a biotechnology research company based in Alpharetta, Georgia. It positions itself as an unconventional life sciences firm focused on health access and global impact, aiming to discover, develop, and distribute health innovations through partnerships with academia, non-governmental organizations, micro-businesses, and multinational corporations. The company seeks to ensure broader access to health innovations so that people can pursue improved well-being and potential, rather than optimizing profit alone. LivFul contributes to the field by collaborating across sectors to bring its innovations to a wide network of partners, including both local and international entities. A notable development in its history is the launch of AKIVA in 2017, a plant-based, DEET-free insect repellent designed to address insect-borne diseases without traditional chemicals. Recent activity includes partnerships with organizations such as Konga Health (and related entities) to introduce Akiva in Nigeria, reflecting ongoing efforts to broaden distribution and impact through strategic collaborations.

Section iconCompany Overview

Website
livful.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $12M

    LivFul, Inc. has raised a total of $12M of funding over 6 rounds. Their latest funding round was raised on Dec 16, 2025 in the amount of $1.5M as a Venture Round.

  • $25M - $50M

    LivFul, Inc.'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.